Pacific Biosciences of California, Inc.: net_income
| Value | {"amount": -306700000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2023-01-01 – 2023-12-31 |
| Status | current |
| Entity | Pacific Biosciences of California, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T12:22:27.402567+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/e5ae0900-37c8-47bf-9bf2-f5dfb7497052
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001299130-26-000064Retrieved: 2026-08-19T12:22:27.402567+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001299130/net-income/2023-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/e5ae0900-37c8-47bf-9bf2-f5dfb7497052
History
- supersedes {"amount": -306735000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} (evidence 0001299130-24-000054)